SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Unquoted Biotechs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (190)7/25/2007 8:53:41 AM
From: nigel bates   of 253
 
Hey, one might just make it to the market before getting bought...

July 25 (Reuters) - Biotechnology company Archemix Corp. filed with U.S. regulators on Wednesday to raise up to $69 million in an initial public offering of common stock.

Banc of America Securities LLC, Bear, Stearns & Co. Inc. and Cowen and Co. are underwriting the IPO, the Cambridge, Massachusetts-based company told the U.S. Securities and Exchange Commission in a preliminary prospectus.

The filing did not reveal how many shares the company planned to sell or their expected price, but said it had applied for a Nasdaq listing under the symbol "ARCH."...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext